The DGAV, authorized SYVAZUL BTV3, Syva’s vaccine against bluetongue serotype 3.
The DGAV (General Directorate of Food and Veterinary in Portugal) grants authorization under Art. 110 (2) of Regulation (EU) 2019/6 for the emergency use of Syvazul BTV3 on Thursday 10 October.
Syva announces that the first doses of its Syvazul BTV3 vaccine will be available in Portugal to initiate immunisation against the disease in the coming weeks.
In September 2023, Bluetongue serotype 3 was detected for the first time in the Netherlands and spread rapidly to neighbouring countries. In September 2024, the first outbreaks were detected in the region of Évora, and subsequently in Spain, with vaccination starting in early October in Spain. Bluetongue serotype 3 has been particularly aggressive in both sheep and cattle, causing high mortality in sheep and severe clinical signs in cattle.
Vaccination is the most effective method to control Bluetongue.
Syvazul BTV3 is indicated for active immunization of sheep and cattle to reduce the clinical symptoms and viraemia caused by Bluetongue serotype 3. Syvazul BTV3 is a vaccine against Bluetongue serotype 3 that has been granted temporary authorization for use in the Netherlands, Belgium, Germany, Austria, Spain and Portugal in accordance with Art. 110 (2) of Regulation (EU) 2019/6. It is also approved for emergency use in the UK. Since the first authorization, more than 4 million doses have already been applied in these countries. For more information : https://www.dgav.pt/destaques/conteudo/autorizacao-temporaria-de-utilizacao-da-vacina-syvazul-btv-3/
You may also be interested in
30 January, 2025
Syvac® EH Marker, the first and only DIVA vaccine against EHD, is now authorized in Belgium
Syva is pleased to announce that the FAMHP/FAGG has granted emergency use authorization for its marker (DIVA) vaccine against EHD in accordance with Article 110(2) of Regulation (EU) 2019/6 for use in cattle and deer.
24 January, 2025
Call for the 28th edition of the Syva Award International for the best doctoral thesis in Animal Health
We are pleased to remind you that the call for applications for the 28th Syva Award International is open until 18 February 2025. We also remind you that for two years now, the Syva Award International is no longer limited to Spanish candidates, but invites all doctoral students of any nationality who have submitted their thesis in animal health...
22 January, 2025
Syva receives a positive opinion for Syvazul BTV 3 vaccine from the CVMP of the European Medicines Agency (EMA).
On 15 January 2025, the Committee for Medicinal Products for Veterinary Use (CVMP) issued a positive opinion recommending the granting of a marketing authorization for Syvazul BTV 3 vaccine. This step forward marks an important milestone in the fight against Bluetongue, and Syva is proud to be at the forefront of this innovation.